Td Asset Management Inc Celldex Therapeutics, Inc. Transaction History

Td Asset Management Inc

$106 Billion
Q4 2024

A detailed history of Td Asset Management Inc transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 143,878 shares of CLDX stock, worth $2.92 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

143,878

Previous 164,078 12.31%

Holding current value

$2.92 Million

Previous $5.57 Million 34.77%

% of portfolio

0.0%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$23.31 - $32.4 $470,862 - $654,480	-20,200 Reduced 12.31%	143,878 $3.64 Million
Q3 2024 Nov 01, 2024	SELL	$32.06 - $44.56 $820,736 - $1.14 Million	-25,600 Reduced 13.5%	164,078 $5.57 Million
Q2 2024 Aug 02, 2024	SELL	$32.76 - $42.56 $1.17 Million - $1.52 Million	-35,800 Reduced 15.88%	189,678 $7.02 Million
Q1 2024 May 08, 2024	BUY	$35.22 - $51.88 $6.1 Million - $8.98 Million	173,156 Added 330.94%	225,478 $9.46 Million
Q4 2023 Feb 12, 2024	SELL	$22.61 - $40.65 $284,886 - $512,190	-12,600 Reduced 19.41%	52,322 $2.08 Million
Q3 2023 Oct 27, 2023	BUY	$25.45 - $37.46 $826,132 - $1.22 Million	32,461 Added 100.0%	64,922 $1.79 Million
Q2 2023 Aug 09, 2023	SELL	$30.29 - $38.28 $402,857 - $509,124	-13,300 Reduced 29.06%	32,461 $1.1 Million
Q1 2023 May 10, 2023	SELL	$34.78 - $47.43 $330,410 - $450,585	-9,500 Reduced 17.19%	45,761 $1.65 Million
Q4 2022 Feb 06, 2023	BUY	$27.78 - $45.38 $211,128 - $344,888	7,600 Added 15.95%	55,261 $2.46 Million
Q3 2022 Nov 07, 2022	BUY	$22.7 - $37.57 $249,700 - $413,270	11,000 Added 30.0%	47,661 $1.35 Million
Q2 2022 Aug 04, 2022	SELL	$20.5 - $37.33 $761,944 - $1.39 Million	-37,168 Reduced 50.34%	36,661 $988,000
Q1 2022 May 10, 2022	BUY	$27.64 - $39.32 $317,860 - $452,180	11,500 Added 18.45%	73,829 $2.52 Million
Q3 2021 Nov 09, 2021	BUY	$28.95 - $55.99 $503,730 - $974,226	17,400 Added 38.73%	62,329 $3.37 Million
Q2 2021 Aug 11, 2021	BUY	$20.71 - $35.37 $457,256 - $780,934	22,079 Added 96.63%	44,929 $1.97 Million
Q1 2021 May 14, 2021	BUY	$16.19 - $29.91 $104,425 - $192,919	6,450 Added 39.33%	22,850 $471,000
Q4 2020 Feb 16, 2021	BUY	$14.99 - $22.75 $245,836 - $373,100	16,400 New	16,400 $287,000

Others Institutions Holding CLDX

# of Institutions

197

Shares Held

69.7M

Call Options Held

960K

Put Options Held

675K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $950M
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Celldex Therapeutics, Inc. Transaction History